CHARLA GRANBERRY: Open Payments
NPI 1457486193 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$721 in 38 payments from 16 companies in 2025. Trend: 2023 $405 · 2024 $500 · 2025 $721
Food & beverage: $721
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 7 | $155 |
| Novo Nordisk Inc | 9 | $149 |
| PFIZER INC. | 4 | $81 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Corcept Therapeutics | 1 | $42 |
| Exact Sciences Corporation | 2 | $33 |
| Astellas Pharma US Inc | 2 | $32 |
| Amgen Inc. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| Dexcom, Inc. | 1 | $23 |
Products named: FREESTYLE LIBRE 3, Wegovy, Ozempic, XIFAXAN, Korlym, ELIQUIS, Cologuard Collection Kit, Veozah.
Industry payments across TX — which companies pay providers there.
